Rafael Holdings, Inc. SEC filings RFL
Rafael Holdings, Inc. has 409 filings in SEC EDGAR's recent list, going back to Oct 31, 2017. Its latest annual report, Form 10-K, was filed on Oct 29, 2026 for the period ended Jul 31, 2026. The latest quarterly report (Form 10-Q) was filed on Jun 11, 2026, covering the quarter ended Apr 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations, regulation fd disclosure, other events). The company's fiscal year ends on July 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Nov 18, 2025 | Jan 8, 2026 |
| DEF 14A | Proxy statement | Nov 19, 2024 | Jan 9, 2025 |
| DEF 14A | Proxy statement | Nov 20, 2023 | Jan 10, 2024 |
| DEF 14A | Proxy statement | Nov 28, 2022 | Jan 23, 2023 |
| DEF 14A | Proxy statement | Nov 24, 2021 | Jan 19, 2022 |
| DEF 14A | Proxy statement | Nov 23, 2020 | Jan 13, 2021 |
| DEF 14A | Proxy statement | Nov 21, 2019 | Jan 15, 2020 |
| DEF 14A | Proxy statement | Nov 27, 2018 | Jan 10, 2019 |
| PRE 14A | Preliminary proxy statement | Nov 15, 2018 | Nov 15, 2018 |
Showing 9 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RFL (NYSE)
- Fiscal year ends
- July 31
- Incorporated in
- DE
- Headquarters
- Newark, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1713863
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.